SECURITIES AND EXCHANGE COMMISSION 
WASHINGTON, D.C. 20549 
FORM 10-Q





|(Mark One) |  |                                                       | 
|---------- |  | ----------------------------------------------------- | 
|           |  |                                                       | 
|X          |  | QUARTERLY REPORT UNDER SECTION 13 OR 15(d)            | 
|           |  | OF THE SECURITIES EXCHANGE ACT OF 1934                | 
|           |  | For the quarterly period ended September
    30, 2007 | 
|           |  | OR                                                    | 
|           |  |                                                       | 
|           |  |                                                       | 
|           |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR
    15(d) | 
|           |  | OF THE SECURITIES EXCHANGE ACT OF 1934                | 

For the transition period from ________
to ________

Commission File Number 001-14789GENTEK INC.(Exact
name of registrant as specified in its charter)

|                                                     | Delaware                                                       |  | 02-0505547                             
|---------------------------------------------------- | -------------------------------------------------------------- |  | ---------------------------------------
|                                                     | (State of other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)
|                                                    
|                                                     | 90 East Halsey Road                                            |  |                                        
|                                                     | Parsippany, New Jersey                                         |  | 07054                                  
|                                                     | (Address of principal executive offices)                       |  | (Zip Code)                             
|                                                    
|(973)  515
 3221                                    
|(Registrants telephone number, including area code)



|Indicate by check mark whether the registrant
        (1) has filed all reports required to be filed by Section 13 or 15(d)
        of the Securities Exchange Act of 1934 during the preceding 12 months
        (or for such shorter period that the registrant was required to file
        such reports), and (2) has been subject to such filing requirements for
    the past 90 days.
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Yes      X           No                                                                                                                                                                                                                                                                                                                                                                     
|                                                                                                                                                                                                                                                                                                                                                                                            
|                                                                                                                                                                                                                                                                                                                                                                                            
|Indicate by check mark whether the registrant
        is a large accelerated filer, an accelerated filer, or a non-accelerated
        filer. See definition of accelerated filer and large accelerated
        filer in Rule 12b-2 of the ExchangeAct.
    (Check One):                                                                                                                  
|Large Accelerated Filer ______           Accelerated
          Filer        XNon-accelerated
    filer ______                                                                                                                                                                                                                                                                               
|                                                                                                                                                                                                                                                                                                                                                                                            
|Indicate by check mark whether the registrant
    is a shell company (as defined in Rule 12b-2 of the Exchange Act).                                                                                                                                                                                                                                                                        
|Yes                 NoX                                                                                                                                                                                                                                                                                                                                                                     
|                                                                                                                                                                                                                                                                                                                                                                                            
|Indicate by checkmark whether the registrant
        has filed all documents and reports required to be filed by Sections
        12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to
    the distribution of securities under a plan confirmed by a court.                                                                                                                
|Yes      X           No                                                                                                                                                                                                                                                                                                                                                                     
|                                                                                                                                                                                                                                                                                                                                                                                            
|The number of outstanding shares of the Registrants
    Common Stock as of October 31, 2007 was 10,605,469.                                                                                                                                                                                                                                                                                







---






GENTEK INC.FORM 10-QQUARTERLY PERIOD ENDED SEPTEMBER 30, 2007INDEX

|                                                                                     |                                                             |      | Page No.
|------------------------------------------------------------------------------------ | ----------------------------------------------------------- | ---- | --------
|PART I. FINANCIAL INFORMATION:                                                       |                                                             |     
|Item 1.                                                                              | Financial Statements                                        |      |         
|Condensed Consolidated Statements of Operations  Three and Nine Months              |                                                             |     
|Ended September 30, 2007 and 2006                                                    |                                                             | 1   
|Condensed Consolidated Balance Sheets September 30, 2007 and                         |                                                             |     
|December 31, 2006 (as Restated)                                                      |                                                             | 2   
|Condensed Consolidated Statements of Cash Flows Nine Months                         |                                                             |     
|Ended September 30, 2007 and 2006 (as Restated)                                      |                                                             | 3-4 
|Condensed Consolidated Statement of Changes in Equity  Year ended December 31, 2006 |                                                             |     
|(as Restated) and Nine Months Ended September 30, 2007                               |                                                             | 5   
|Notes to the Condensed Consolidated Financial Statements                             |                                                             | 6-16
|Item 2.                                                                              | Managements Discussion and Analysis of Financial           |      |         
|                                                                                     | Condition and Results of Operations                         |      | 17-24   
|Item 3.                                                                              | Quantitative and Qualitative Disclosures About Market Risk  |      | 24-25   
|Item 4.                                                                              | Controls and Procedures                                     |      | 25      
|PART II. OTHER INFORMATION:                                                          |                                                             |     
|Item 1.                                                                              | Legal Proceedings                                           |      | 26      
|Item 1A.                                                                             | Risk Factors                                                |      | 26      
|Item 2.                                                                              | Unregistered Sales of Equity Securities and Use of Proceeds |      | 26      
|Item 3.                                                                              | Defaults Upon Senior Securities                             |      | 26      
|Item 4.                                                                              | Submission of Matters to a Vote of Security Holders         |      | 26      
|Item 5.                                                                              | Other Information                                           |      | 26      
|Item 6.                                                                              | Exhibits                                                    |      | 27-30   
|SIGNATURES                                                                           |                                                             | 31  

---



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

GENTEK INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(unaudited)

|                                                       |      | Three Months Ended |   |      | Nine Months Ended |        
|------------------------------------------------------ | ---- | ------------------ | - | ---- | ----------------- | -------
|                                                       |      | September 30,      |   |      | September 30,     |        
|                                                       | 2007 |                    |   | 2006 |                   |        
|Net revenues                                           | $    | 151,334            |   |      | $                 | 158,545
|Cost of sales                                          |      | 128,738            |   |      |                   | 131,169
|Selling, general and administrative expense            |      | 13,153             |   |      |                   | 13,450 
|Net (gain) on disposition of long-term assets          |      | (10,068            | ) |      |                   | (165   
|Restructuring and impairment charges                   |      | 1,708              |   |      |                   | 246    
|Pension and postretirement liability curtailment       |      |                    |   |      |                   |        
|(gains)                                                |      | (2,565             | ) |      |                   | --     
|Operating profit                                       |      | 20,368             |   |      |                   | 13,845 
|Interest expense                                       |      | 5,404              |   |      |                   | 6,314  
|Interest income                                        |      | 42                 |   |      |                   | 186    
|Other (income) expense, net                            |      | 44                 |   |      |                   | 31     
|Income from continuing operations before               |      |                    |   |      |                   |        
|income taxes                                           |      | 14,962             |   |      |                   | 7,686  
|Income tax provision                                   |      | 6,387              |   |      |                   | 3,416  
|Income from continuing operations                      |      | 8,575              |   |      |                   | 4,270  
|Income (loss) from discontinued operations (net of tax |      |                    |   |      |                   |        
|provision (benefit) of $1,098, $ (1,267), $(225) and   |      |                    |   |      |                   |        
|$(3,366), respectively)                                |      | 608                |   |      |                   | (1,388 
|Net income                                             | $    | 9,183              |   |      | $                 | 2,882  
|                                                      
|Income per common share  basic:                       |      |                    |   |      |                   |        
|Income from continuing operations                      | $    | 0.83               |   |      | $                 | 0.42   
|Income (loss) from discontinued operations             |      | 0.06               |   |      |                   | (0.14  
|Net income                                             | $    | 0.89               |   |      | $                 | 0.28   
|                                                      
|Income per common share  assuming dilution:           |      |                    |   |      |                   |        
|Income from continuing operations                      | $    | 0.75               |   |      | $                 | 0.38   
|Income (loss) from discontinued operations             |      | 0.05               |   |      |                   | (0.12  
|Net income                                             | $    | 0.80               |   |      | $                 | 0.26   
|                                                       |      |                    |   |      |                   |        

See
  the accompanying notes to the condensed consolidated financial statements.


-1-

---






GENTEK INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands, except share data)(unaudited)

|                                                                     |  |   | September 30, |   |  |   | December 31,  |  
|-------------------------------------------------------------------- |  | - | ------------- | - |  | - | ------------- | -
|                                                                     |  |   | 2007          |   |  |   | 2006          |  
|                                                                     |  |   |               |   |  |   | As Restated - |  
|                                                                     |  |   |               |   |  |   | See Note 13   |  
|ASSETS                                                               |  |   |               |   |  |   |               |  
|Current assets:                                                      |  |   |               |   |  |   |               |  
|Cash and cash equivalents                                            |  | $ | 12,936        |   |  | $ | 5,237         |  
|Receivables, net                                                     |  |   | 88,548        |   |  |   | 77,305        |  
|Inventories                                                          |  |   | 51,213        |   |  |   | 46,885        |  
|Deferred income taxes                                                |  |   | 32,438        |   |  |   | 31,578        |  
|Assets held for sale                                                 |  |   | 5,602         |   |  |   | 136,294       |  
|Other current assets                                                 |  |   | 6,162         |   |  |   | 6,511         |  
|Total current assets                                                 |  |   | 196,899       |   |  |   | 303,810       |  
|Property, plant and equipment, net                                   |  |   | 209,220       |   |  |   | 224,102       |  
|Goodwill                                                             |  |   | 142,416       |   |  |   | 139,497       |  
|Intangible assets, net                                               |  |   | 49,962        |   |  |   | 54,703        |  
|Other assets                                                         |  |   | 6,034         |   |  |   | 8,094         |  
|Total assets                                                         |  | $ | 604,531       |   |  |   | 730,206       |  
|                                                                    
|LIABILITIES AND EQUITY                                               |  |   |               |   |  |   |               |  
|Current liabilities:                                                 |  |   |               |   |  |   |               |  
|Accounts payable                                                     |  | $ | 37,485        |   |  |   | 42,639        |  
|Accrued liabilities                                                  |  |   | 58,398        |   |  |   | 56,181        |  
|Current portion of long-term debt                                    |  |   | 3,623         |   |  |   | 4,612         |  
|Liabilities of businesses held for sale                              |  |   | --            |   |  |   | 32,753        |  
|Total current liabilities                                            |  |   | 99,506        |   |  |   | 136,185       |  
|Long-term debt                                                       |  |   | 245,398       |   |  |   | 340,687       |  
|Pension and postretirement liabilities                               |  |   | 67,433        |   |  |   | 85,501        |  
|Other liabilities                                                    |  |   | 72,855        |   |  |   | 69,354        |  
|Total liabilities                                                    |  |   | 485,192       |   |  |   | 631,727       |  
|Equity:                                                              |  |   |               |   |  |   |               |  
|Preferred Stock, $.01 par value; authorized: 10,000,000 shares; none |  |   |               |   |  |   |               |  
|issued or outstanding                                                |  |   | --            |   |  |   | --            |  
|Common Stock, no par value; authorized: 100,000,000 shares; issued:  |  |   |               |   |  |   |               |  
|10,639,506 and 10,359,716 shares at September 30, 2007 and December  |  |   |               |   |  |   |               |  
|31, 2006, respectively                                               |  |   | 86,320        |   |  |   | 83,516        |  
|Warrants                                                             |  |   | 7,824         |   |  |   | 8,355         |  
|Accumulated other comprehensive income                               |  |   | 14,085        |   |  |   | 8,550         |  
|Retained earnings (deficit)                                          |  |   | 12,090        |   |  |   | (1,678        | )
|Treasury stock, at cost: 34,037 and 12,198 shares at September 30,   |  |   |               |   |  |   |               |  
|2007 and December 31, 2006, respectively                             |  |   | (980          | ) |  |   | (264          | )
|Total equity                                                         |  |   | 119,339       |   |  |   | 98,479        |  
|Total liabilities and equity                                         |  | $ | 604,531       |   |  | $ | 730,206       |  
|                                                                    
|                                                                     |  |   |               |   | 

See
  the accompanying notes to the condensed consolidated financial statements.


-2-

---






GENTEK INC.CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands)(unaudited)

|                                                            |      | Nine Months Ended |     
|----------------------------------------------------------- | ---- | ----------------- | ----
|                                                            |      | September 30,     |     
|                                                            | 2007 |                   | 2006
|                                                            |      |                   |     
|                                                            |      |                   |     
|Cash flows from operating activities:                       |      |                   |     
|Net income                                                  | $    | 10,967            |     
|Adjustments to reconcile net income to net cash provided by |      |                   |     
|operating activities:                                       |      |                   |     
|Discontinued operations                                     |      | 6,701             |     
|Pension and postretirement liability curtailment gains      |      | (3,260            | )   
|Depreciation and amortization                               |      | 27,456            |     
|Asset impairment charge                                     |      | 925               |     
|Net (gain) on disposition of long-term assets               |      | (10,036           | )   
|Long-term incentive plan costs, net                         |      | 2,972             |     
|Excess tax benefit from stock option exercises              |      | (618              | )   
|Increase in receivables                                     |      | (9,736            | )   
|Increase in inventories                                     |      | (3,547            | )   
|(Increase) decrease in deferred tax assets                  |      | (3,461            | )   
|Increase (decrease) in accounts payable                     |      | (3,007            | )   
|Increase in accrued liabilities                             |      | 7,521             |     
|Change in other liabilities and assets, net                 |      | (2,952            | )   
|Net cash provided by continuing operations                  |      | 19,925            |     
|Net cash provided by (used for) discontinued operations     |      | (1,937            | )   
|Net cash provided by operating activities                   |      | 17,988            |     
|Cash flows from investing activities:                       |      |                   |     
|Capital expenditures                                        |      | (21,032           | )   
|Proceeds from sales of long-term assets                     |      | 14,997            |     
|Proceeds from short-term investments                        |      | --                |     
|Acquisition of businesses, net of cash acquired*            |      | (3,203            | )   
|Net cash used for continuing operations                     |      | (9,238            | )   
|Net cash provided by discontinued operations                |      | 96,945            |     
|Net cash provided by (used for) investing activities        |      | 87,707            |     
|Cash flows from financing activities:                       |      |                   |     
|Proceeds from revolving credit facility                     |      | 77,750            |     
|Repayment of revolving credit facility                      |      | (87,750           | )   
|Issuance of long-term debt                                  |      | 50,000            |     
|Repayment of long-term debt                                 |      | (135,102          | )   
|Deferred financing costs                                    |      | (378              | )   
|Dividends                                                   |      | --                |     
|Exercise of stock options and warrants                      |      | 694               |     
|Excess tax benefits from stock option exercises             |      | 618               |     
|Acquisition of treasury stock                               |      | (716              | )   
|Repurchase and retirement of common stock                   |      | (2,250            | )   
|Net cash used for continuing operations                     |      | (97,134           | )   
|Net cash used for discontinued operations                   |      | (1,393            | )   
|Net cash used for financing activities                      |      | (98,527           | )   
|Effect of exchange rate changes on cash                     |      | 531               |     
|Increase (decrease) in cash and cash equivalents            |      | 7,699             |     
|Cash and cash equivalents at beginning of period            |      | 5,237             |     
|Cash and cash equivalents at end of period                  | $    | 12,936            |     

-3-

---






GENTEK INC.CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS(In
thousands)(unaudited)

|Supplemental information:                        |  |   |        |   |   |         |  
|------------------------------------------------ |  | - | ------ | - | - | ------- | -
|Cash paid (refunded) for income taxes            |  | $ | 3,532  |   | $ | (394    | )
|Cash paid for interest                           |  | $ | 18,677 |   | $ | 22,678  |  
|Capital expenditures incurred but not yet paid   |  | $ | 3,066  |   | $ | 2,907   |  
|                                                
|*Acqusition of businesses, net of cash acquired: |  |   |        |   |   |         |  
|Working capital, other than cash                 |  | $ | (215   | ) | $ | (10,508 | )
|Property, plant and equipment                    |  |   | (87    | ) |   | (22,666 | )
|Other assets                                     |  |   | (2,901 | ) |   | (9,101  | )
|Non current liabilities                          |  |   | --     |   |   | 2,437   |  
|Total cash used to acquire businesses            |  | $ | (3,203 | ) | $ | (39,838 | )

See the accompanying notes to the condensed consolidated financial statements.

-4-

---



GENTEK INC.CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITYFor the Year Ended December 31, 2006 (as Restated  See Note 13)and the Nine Months Ended September 30, 2007(In thousands)(unaudited)

|                                                 |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  | Accumulated |        |          |  |   |        |   |  |  
|------------------------------------------------ |  | ------ | ------ | ------------ |  | -------- | ---- | ----- |  | ------------- | ----- | ------------- |  | -------- | ---- | - |  | ----------- | ------ | -------- |  | - | ------ | - |  | -
|                                                 |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  | Other       |        | Retained |  |   |        |  
|                                                 |  | Common |        | Unearned     |  |          |      |       |  | Treasury      |       | Comprehensive |  | Earnings |      |   |  |            
|                                                 |  | Stock  |        | Compensation |  | Warrants |      | Stock |  | Income (Loss) |       | (Deficit)     |  | Total   
|                                                
|                                                
|Balance at January 1, 2006                       |  | $      | 81,395 |              |  | $        | (859 | )     |  | $             | 8,361 |               |  | $        | (86  | ) |  | $           | (3,861 | )        |  | $ | 425    |   |  | $
|Components of comprehensive income:              |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|Net loss                                         |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | --     |          |  |   | (2,103 | ) |  |  
|Minimum pension liability adjustment (net        |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|of tax of $2,494) (as Restated see Note 13)      |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | 3,811  |          |  |   | --     |   |  |  
|Foreign currency translation adjustments         |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|(net of tax of $59)                              |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | 92     |          |  |   | --     |   |  |  
|Change in unrealized gain on derivative          |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|instruments (net of tax of $157)                 |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | 239    |          |  |   | --     |   |  |  
|Comprehensive income (as Restated see Note 13)   |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|Adjustment to initially apply FASB Statement     |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|No. 158 (net of tax of $1,198) (as Restated      |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|see Note 13)                                     |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | 8,269  |          |  |   | --     |   |  |  
|Long term incentive plan grants, net             |  |        | 1,243  |              |  |          | 859  |       |  |               | --    |               |  |          | --   |   |  |             | --     |          |  |   | --     |   |  |  
|Exercise of warrants                             |  |        | 48     |              |  |          | --   |       |  |               | (6    | )             |  |          | --   |   |  |             | --     |          |  |   | --     |   |  |  
|Exercise of stock options                        |  |        | 830    |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | --     |          |  |   | --     |   |  |  
|Acquisition of treasury stock                    |  |        | --     |              |  |          | --   |       |  |               |       |               |  |          | (178 | ) |  |             | --     |          |  |   | --     |   |  |  
|Balance at December 31, 2006 (as Restated see    |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|Note 13)                                         |  |        | 83,516 |              |  |          | --   |       |  |               | 8,355 |               |  |          | (264 | ) |  |             | 8,550  |          |  |   | (1,678 | ) |  |  
|Cumulative effect of change in accounting for    |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|uncertain tax positions                          |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | --     |          |  |   | 2,801  |   |  |  
|Components of comprehensive income:              |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|Net income                                       |  |        | --     |              |  |          | --   |       |  |               | -     |               |  |          | --   |   |  |             | --     |          |  |   | 10,967 |   |  |  
|Pension and postretirement liability adjustments |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|(net of tax of $4,200)                           |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | 6,421  |          |  |   | --     |   |  |  
|Foreign currency translation adjustments         |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|(net of tax of $(4))                             |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | (7     | )        |  |   | --     |   |  |  
|Change in unrealized gain on derivative          |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|instruments (net of tax of $(575))               |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | (879   | )        |  |   | --     |   |  |  
|Comprehensive income                             |  |        |        |              |  |          |      |       |  |               |       |               |  |          |      |   |  |             |        |          |  |   |        |   |  |  
|Long term incentive plan grants, net             |  |        | 3,829  |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | --     |          |  |   | --     |   |  |  
|Exercise of stock options                        |  |        | 694    |              |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | --     |          |  |   | --     |   |  |  
|Acquisition of treasury stock                    |  |        | --     |              |  |          | --   |       |  |               | --    |               |  |          | (716 | ) |  |             | --     |          |  |   | --     |   |  |  
|Repurchase and retirement of common stock        |  |        | (2,250 | )            |  |          | --   |       |  |               | --    |               |  |          | --   |   |  |             | --     |          |  |   | --     |   |  |  
|Exercise of warrants                             |  |        | 531    |              |  |          | --   |       |  |               | (531  | )             |  |          | --   |   |  |             | --     |          |  |   | --     |   |  |  
|Balance at September 30, 2007                    |  | $      | 86,320 |              |  | $        | --   |       |  | $             | 7,824 |               |  | $        | (980 | ) |  | $           | 14,085 |          |  | $ | 12,090 |   |  | $

See the accompanying notes to the condensed consolidated financial statements.

-5-

---






GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Dollars in thousands, except per share data)(unaudited)

Note 1  Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission.  In the opinion
of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.  Operating results for the nine months ended September 30, 2007 are not indicative of the results that may
be expected for the year ending December 31, 2007. These statements should be read in conjunction with the financial statements and the notes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2006.

On April 27, 2007, the Company signed an agreement to sell its wholly owned subsidiary Defiance Testing and Engineering Services, Inc. The transaction was completed on July 17, 2007.
Accordingly, this business has been classified as discontinued operations. See Note Number 11.

Note 2  Summary of Significant Accounting Policies

In June 2006, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 48,Accounting for Uncertainty in Income Taxes, an
Interpretation of FASB Statement No. 109(FIN 48). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in a companys financial statements and prescribes a recognition
threshold and measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. The interpretation also provides guidance on derecognition, classification, interest and
penalties, accounting in interim periods, disclosure and transition. The Company adopted FIN 48 on January 1, 2007. The adoption, which was accounted for as a cumulative effect adjustment, resulted in an increase to the January 1, 2007 balance of
retained earnings (deficit) of $2,801.  The total amount of unrecognized tax benefits as of January 1, 2007 was $13,546, of which $11,484 would, if recognized, affect the effective tax rate.

The Company and its affiliates are subject to tax in various jurisdictions, including the United States, various states, Canada and several other foreign jurisdictions.  The Company, joined by
its domestic subsidiaries, files a consolidated income tax return for Federal income tax purposes. With few exceptions, the Company is no longer subject to income tax examinations by tax authorities for tax years before 2002. The Company recognizes
interest and penalties related to uncertain tax positions as a component of the provision for income taxes. As of January 1, 2007, the Company had $1,683 accrued for interest and penalties. There were no significant changes to any of these
amounts during the nine months ended September 30, 2007. During the next twelve months, it is reasonably possible that the total amount of unrecognized tax benefits will significantly change by up to approximately $8,000 due to the expiration of
statute of limitations or the settlement of examinations.

In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements, (SFAS 157), to define fair value, establish a framework for measuring fair value in accordance with
generally accepted accounting principles and expand disclosures about fair value measurements. SFAS 157 requires quantitative disclosures using a tabular format in all periods (interim and annual) and qualitative disclosures about the valuation
techniques used to measure fair value in all annual periods. The provisions of this Statement shall be effective for financial statements issued for fiscal years beginning after November 15, 2007 and interim periods within those fiscal years. The
Company will be required to adopt the provisions of this statement as of January 1, 2008. The Company is currently evaluating the impact of adopting SFAS 157.

-6-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

In February 2007, the FASB issued SFAS No. 159 The Fair Value Option for Financial Assets and Financial Liabilities  including an Amendment of SFAS No. 115, (SFAS No. 159),
which permits an entity to measure many financial assets and financial liabilities at fair value that are not currently required to be measured at fair value. Entities that elect the fair value option will report unrealized gains and losses in
earnings at each subsequent reporting date. The fair value option may be elected on an instrument-by instrument basis, with few exceptions. SFAS No. 159 amends previous guidance to extend the use of the fair value option to available-for-sale and
held-to-maturity securities. The Statement also establishes presentation and disclosure requirements to help financial statement users understand the effect of the election. SFAS No. 159 is effective as of the beginning of the first fiscal year
beginning after November 15, 2007. The Company is currently evaluating the impact of adopting SFAS No. 159.

Included in selling, general and administrative expense for the nine months ended September 30, 2007 is a gain of $736 for a settlement related to prior insurance costs.

Gains on disposition of long-term assets in prior periods have been reclassified to conform to the current period presentation.

Note 3  Comprehensive Income

Total comprehensive income is comprised of net income, pension and postretirement liability adjustments, foreign currency translation adjustments and the change in unrealized gains and losses
on derivative financial instruments. Total comprehensive income for the three months ended September 30, 2007 and 2006 was $7,221 and $1,246, respectively. Total comprehensive income for the nine months ended September 30, 2007 and 2006 was
$16,502 and $11,257, respectively.

Note 4  Earnings Per Share

The computation of basic earnings per share is based on the weighted average number of common shares outstanding during the period. The computation of diluted earnings per share assumes the
foregoing and, in addition, the exercise of all warrants, stock options and restricted stock, using the treasury stock method.

The shares outstanding used for basic and diluted earnings
per common share are reconciled as follows:

|                                       |  | Three Months Ended |  | Nine Months Ended
|-------------------------------------- |  | ------------------ |  | -----------------
|                                       |  | September 30,      |  | September 30,    
|                                       |  | 2007               |  | 2006             
|Basic earnings per common share:       |  |                    |  |                  
|Weighted average common shares         |  |                    |  |                  
|outstanding                            |  | 10,372,085         |  | 10,182,961       
|Diluted earnings per common share:     |  |                    |  |                  
|Weighted average common shares         |  |                    |  |                  
|outstanding                            |  | 10,372,085         |  | 10,182,961       
|Warrants, options and restricted stock |  | 1,125,351          |  | 1,019,310        
|Total                                  |  | 11,497,436         |  | 11,202,271       

-7-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

For the three months ended September 30, 2007 and 2006, potentially dilutive securities totaling 228,652 and 112,096, respectively, were not included in the computation of diluted earnings per
common share due to their antidilutive effect. For the nine months ended September 30, 2007 and 2006, potentially diluted securities totaling 139,237 and 1,068,100, respectively, were not included in the computation of diluted earnings per common
share due to their antidilutive effect.

Note 5  Inventories

|                                           |  |            |  | September 30, |         | December 31,
|------------------------------------------ |  | ---------- |  | ------------- | ------- | ------------
|                                           |  |            |  | 2007          |         | 2006        
|Raw materials                              |  |            |  | $             | 30,387  |             
|Work in process                            |  |            |  |               | 6,146   |             
|Finished products                          |  |            |  |               | 13,314  |             
|Supplies and containers                    |  |            |  |               | 1,366   |             
|                                           |  |            |  | $             | 51,213  |             
|                                          
|Note 6  Long-Term Debt                    |  |            |  |               |         |             
|                                          
|                                           |  |            |  | September 30, |         | December 31,
|                                           |  | Maturities |  | 2007          |         | 2006        
|Revolving credit facility  floating rates |  | 2010       |  | $             | --      |             
|First lien term loans  floating rates     |  | 2011       |  |               | 247,182 |             
|Second lien term loan  floating rates     |  | 2012       |  |               | --      |             
|Other debt  various rates                 |  | 2007-2018  |  |               | 1,839   |             
|Total debt                                 |  |            |  |               | 249,021 |             
|Less: current portion                      |  |            |  |               | 3,623   |             
|Net long-term debt                         |  |            |  | $             | 245,398 |             

As of September 30, 2007, the weighted-average interest rates in effect for the first lien term loan was 7.53 percent.

On March 19, 2007, the Company completed an amendment to its credit facilities which enabled it to increase borrowings under the first lien term loan by $50,000 and to use these borrowings
and the net proceeds from the Noma wire and cable harness assembly business sale to redeem the entire second lien term loan.

On April 26, 2006, the Company entered into amendments of its first and second lien term loan agreements which reduced the interest rate margins by 50 and 150 basis points, respectively. In
addition, the debt holders agreed to allow a redemption of the second lien term loan. On May 1, 2006, the Company repaid $22,000 of its second lien term loan. In connection with the amendments, the Company recorded charges in interest expense of
$3,572 for certain costs related to the amendment and to write-off certain deferred funding costs.

Note 7  Stock Incentive Plans

During the first nine months of 2007, the Company granted the following awards:

-8-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

|                                   |  |                |  | Weighted Average Exercise
|---------------------------------- |  | -------------- |  | -------------------------
|                                   |  | Options/Shares |  | Price/Grant-Date Value   
|Stock options                      |  | 64,129         |  | $ 35.10                  
|Restricted stock                   |  | 43,679         |  | $ 35.05                  
|Performance based restricted stock |  | 164,523        |  | $ 35.09                  

The fair value of each option grant was estimated using the Black Scholes option pricing model utilizing the weighted-average assumptions noted in the following table.

|Dividend yield                     | --    |  
|---------------------------------- | ----- | -
|Expected volatility                | 18.77 | %
|Risk free interest rate            | 4.79  | %
|Expected holding period (in years) | 4     |  
|Weighted average fair value        | $8.39 |  

Compensation cost recorded for stock-based compensation under the long-term incentive plan was $1,192 and $486 for the three months ended September 30, 2007 and 2006, respectively, and
$2,973 and $1,220 for the nine months ended September 30, 2007 and 2006, respectively.

As of September 30, 2007, there was $5,620 of total unrecognized compensation cost that is expected to be recognized over a weighted average period of 2.6 years. The remaining unrecognized
compensation cost for performance based restricted stock may vary each reporting period based on changes in the expected achievement of performance measures.

Note 8  Segment Information

The
segment presentation has been changed to reflect the Companys industrial
wire and fluid transport and handling equipment product lines within corporate
and other. These product lines were formerly included within the manufacturing
segment.

|                                                                                                                                                                                                   |  |   | Three Months Ended |   |  |   | Nine Months Ended |  
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | - | ------------------ | - |  | - | ----------------- | -
|                                                                                                                                                                                                   |  |   | September 30,      |   |  |   | September 30,     |  
|                                                                                                                                                                                                   |  |   | 2007               |   |  |   | 2006              |  
|Net Revenues                                                                                                                                                                                       |  |   |                    |   |  |   |                   |  
|Manufacturing(1)                                                                                                                                                                                   |  | $ | 32,421             |   |  | $ | 38,566            |  
|Performance chemicals                                                                                                                                                                              |  |   | 106,358            |   |  |   | 100,006           |  
|Corporate and other(1)                                                                                                                                                                             |  |   | 12,555             |   |  |   | 19,973            |  
|Consolidated                                                                                                                                                                                       |  | $ | 151,334            |   |  | $ | 158,545           |  
|(1)      Revenues
        of $19,973 and $57,677 for the three and nine months ended September
          30, 2006, respectively, have been restated and included in corporate
          and other.
|                                                                                                                                                                                                  
|                                                                                                                                                                                                   |  |   | Three Months Ended |   |  |   | Nine Months Ended |  
|                                                                                                                                                                                                   |  |   | September 30,      |   |  |   | September 30,     |  
|                                                                                                                                                                                                   |  |   | 2007               |   |  |   | 2006              |  
|Operating Profit                                                                                                                                                                                   |  |   |                    |   |  |   |                   |  
|Manufacturing(1)                                                                                                                                                                                   |  | $ | (797               | ) |  | $ | 2,181             |  
|Performance chemicals                                                                                                                                                                              |  |   | 22,198             |   |  |   | 12,780            |  
|Corporate and other(1)                                                                                                                                                                             |  |   | (1,033             | ) |  |   | (1,116            | )
|Consolidated                                                                                                                                                                                       |  |   | 20,368             |   |  |   | 13,845            |  
|Interest expense                                                                                                                                                                                   |  |   | 5,404              |   |  |   | 6,314             |  
|Other expense (income), net                                                                                                                                                                        |  |   | 2                  |   |  |   | (155              | )
|Consolidated income from continuing                                                                                                                                                                |  |   |                    |   |  |   |                   |  
|operations before income taxes                                                                                                                                                                     |  | $ | 14,962             |   |  | $ | 7,686             |  

-9-

---






GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)



|                                                                                                                                                                                                       |  | Three Months Ended |                    | Nine Months Ended
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |  | ------------------ | ------------------ | -----------------
|                                                                                                                                                                                                       |  | September 30,      |                    | September 30,    
|                                                                                                                                                                                                       |  | 2007               |                    | 2006             
|Capital Expenditures                                                                                                                                                                                   |  |                    |                    |                  
|Manufacturing(1)                                                                                                                                                                                       |  | $                  | 1,815              |                  
|Performance chemicals                                                                                                                                                                                  |  |                    | 4,042              |                  
|Corporate and other(1)                                                                                                                                                                                 |  |                    | 687                |                  
|Consolidated                                                                                                                                                                                           |  | $                  | 6,544              |                  
|(1)      Capital
        expenditures of $22 and $58 for the three and nine months ended September
        30, 2006, respectively, have been restated and included in corporate
        and other.    
|                                                                                                                                                                                                      
|                                                                                                                                                                                                       |  |                    | Three Months Ended |                  
|                                                                                                                                                                                                       |  |                    | September 30,      |                  
|                                                                                                                                                                                                       |  | 2007               |                    | 2006             
|Depreciation and Amortization                                                                                                                                                                          |  |                    |                    |                  
|Manufacturing(1)                                                                                                                                                                                       |  | $                  | 3,115              |                  
|Performance chemicals                                                                                                                                                                                  |  |                    | 5,319              |                  
|Corporate and other(1)                                                                                                                                                                                 |  |                    | 884                |                  
|Consolidated                                                                                                                                                                                           |  | $                  | 9,318              |                  
|(1)      Depreciation
      and amortization of $267 and $801 for the three and nine months
      ended September 30, 2006, respectively, has been restated and included
      in corporate and other.
|                                                                                                                                                                                                      
|                                                                                                                                                                                                       |  |                    |                    |                  
|                                                                                                                                                                                                       |  |                    |                    |                  
|Identifiable Assets                                                                                                                                                                                    |  |                    |                    |                  
|Manufacturing(2)                                                                                                                                                                                       |  |                    |                    |                  
|Performance chemicals(1)                                                                                                                                                                               |  |                    |                    |                  
|Corporate and other(2)                                                                                                                                                                                 |  |                    |                    |                  
|Assets held for sale                                                                                                                                                                                   |  |                    |                    |                  
|Consolidated                                                                                                                                                                                           |  |                    |                    |                  

Note 9  Restructuring and Impairment Charges

During 2007, the Company initiated actions to close its Perrysburg, Ohio facility, which is included in its manufacturing segment.  During 2006, the Company initiated actions to close its
Newark, New Jersey sulfuric acid production facility and its Cleveland, Ohio aluminum sulfate production facility, both of which are included in the performance chemicals segment. These restructuring actions have been substantially completed. The
following tables summarize the Companys expected costs and accruals for these restructuring actions:

|                                                       |  |               |      |   |           | Performance |           | Corporate |       |    |  |  
|------------------------------------------------------ |  | ------------- | ---- | - | --------- | ----------- | --------- | --------- | ----- | -- |  | -
|                                                       |  | Manufacturing |      |   | Chemicals |             | and other |           | Total |   
|Employee
            Termination Costs                 |  |               |      |   |           |             |           |           |       |    |  |  
|Costs incurred
        in prior periods                |  | $             | --   |   |           | $           | 390       |           | $     | -- |  | $
|Costs incurred
        in current period               |  |               | 364  |   |           |             | 174       |           |       | -- |  |  
|Costs anticipated
        to be incurred in the future |  |               | --   |   |           |             | --        |           |       | -- |  |  
|Total costs expected
        to be incurred            |  | $             | 364  |   |           | $           | 564       |           | $     | -- |  | $
|                                                      
|Accrual balance
        at December 31, 2006           |  | $             | --   |   |           | $           | 390       |           | $     | -- |  | $
|Provisions                                             |  |               | 364  |   |           |             | 174       |           |       | -- |  |  
|Amounts paid                                           |  |               | (344 | ) |           |             | (564      | )         |       | -- |  |  
|Accrual balance
        at September 30, 2007          |  | $             | 20   |   |           | $           | --        |           | $     | -- |  | $

-10-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

|                                                       |  |               |        |           | Performance |                     | Corporate |       |    |  |  
|------------------------------------------------------ |  | ------------- | ------ | --------- | ----------- | ------------------- | --------- | ----- | -- |  | -
|                                                       |  | Manufacturing |        | Chemicals |             | and
          other |           | Total |   
|Facility Exit Costs                                    |  |               |        |           |             |                     |           |       |    |  |  
|Costs incurred in prior periods                        |  | $             | --     |           | $           | 212                 |           | $     | -- |  | $
|Costs incurred in current
        period               |  |               | 1,659  |           |             | 1,455               |           |       | -- |  |  
|Costs anticipated to be incurred
        in the future |  |               | --     |           |             | -                   |           |       | -- |  |  
|Total costs expected to be
        incurred            |  | $             | 1,659  |           | $           | 1,667               |           | $     | -- |  | $
|                                                       |  |               |        |           |             |                     |           |       |    |  |  
|Accrual balance at December
        31, 2006           |  | $             | --     |           | $           | 212                 |           | $     | -- |  | $
|Provisions                                             |  |               | 1,659  |           |             | 1,455               |           |       | -- |  |  
|Amounts paid                                           |  |               | (1,659 | )         |             | (1,667              | )         |       | -- |  |  
|Accrual balance at September
        30, 2007          |  | $             | --     |           | $           | --                  |           | $     | -- |  | $

During the third quarter of 2007, the Company recorded impairment charges of $925 to reflect estimated fair values of closed facilities in Waterdown, Ontario, Canada, which is included in the manufacturing segment, and
Saukville, Wisconsin, which is included in the performance chemicals segment. The estimated fair values were determined based upon offers to purchase these facilities.

Note 10  Pension and Other
Postretirement Benefits

|                                           | Three Months Ended |                         |   |      | Nine Months Ended |                        
|------------------------------------------ | ------------------ | ----------------------- | - | ---- | ----------------- | -----------------------
|                                           |                    | September
          30, |   |      |                   | September
          30,
|                                           | 2007               |                         |   | 2006 |                   |                        
|Pension Benefits                           |                    |                         |   |      |                   |                        
|Service cost                               | $                  | 256                     |   |      | $                 | 375                    
|Interest cost                              |                    | 3,384                   |   |      |                   | 3,359                  
|Expected return on
        plan assets     |                    | (3,820                  | ) |      |                   | (3,712                 
|Amortization of net:                       |                    |                         |   |      |                   |                        
|Prior
        service cost                 |                    | 32                      |   |      |                   | 16                     
|Loss                                       |                    | 24                      |   |      |                   | 23                     
|Net periodic benefit
        cost (income) | $                  | (124                    | ) |      | $                 | 61                     
|                                          
|                                           |                    | Three Months Ended      |   |      |                   | Nine Months Ended      
|                                           |                    | September
          30, |   |      |                   | September
          30,
|                                           | 2007               |                         |   | 2006 |                   |                        
|Other Postretirement
            Benefits  |                    |                         |   |      |                   |                        
|Service cost                               | $                  | 280                     |   |      | $                 | 337                    
|Interest cost                              |                    | 641                     |   |      |                   | 669                    
|Expected return on
        plan assets     |                    | --                      |   |      |                   | --                     
|Amortization of net:                       |                    |                         |   |      |                   |                        
|Prior
        service cost (credit)        |                    | (1,264                  | ) |      |                   | (1,086                 
|Loss                                       |                    | 63                      |   |      |                   | 26                     
|Net periodic benefit
        (income)      | $                  | (280                    | ) |      | $                 | (54                    

During the first nine months of 2007, the Company adopted plan amendments that froze pension plan benefit accruals for hourly employees covered by certain collective bargaining agreements, and
announced the

-11-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

closure of one of its manufacturing facilities. These actions resulted in net pension curtailment gains of $50 and $745 for the three and nine months ended September 30, 2007, respectively.

During the second quarter of 2006, the Company notified certain hourly employees covered by certain collective bargaining agreements that their pension plan benefit accruals would be frozen
effective July 1, 2006. These actions resulted in pension curtailment gains of $635 recorded in the second quarter of 2006.

During the second quarter of 2007, the Company implemented plan amendments to one of its postretirement medical plans which cap the Companys cost for providing these benefits. The effect
of these changes was a reduction to the accumulated postretirement benefit obligation of $7,247 which will be amortized as a component of net periodic postretirement benefit cost over the average remaining service period until full eligibility
of active plan participants.

During the third quarter of 2007, the Company completed the closure of one of its manufacturing facilities, resulting in a postretirement liability curtailment gain of $2,515.

Note 11  Discontinued Operations

During April 2006, the Company completed the sale of its cable and wire manufacturing business in Stouffville, Canada. All requirements for classifying this business as held for
sale were met during the first quarter of 2006. Accordingly, the Company recorded an impairment charge of $2,458 in order to reflect assets to be sold at net realizable value, which has been included in income (loss) from discontinued
operations, related to property, plant and equipment and goodwill allocated to the business. This business was formerly reported as part of the manufacturing segment.

On December 22, 2006, the Company announced that it had signed a definitive agreement to sell its Noma wire and cable assembly business to Electrical Components International, Inc. for
$75,000, plus a working capital adjustment of $1,033. The transaction was completed on February 16, 2007. Accordingly, in the fourth quarter of 2006, the Company recorded an impairment charge of $11,907 in order to reflect the net assets
to be sold at net realizable value, which has been included in income (loss) from discontinued operations, related to property, plant and equipment, goodwill and other intangible assets. This business was formerly reported as part of the
manufacturing segment. GenTeks wire and cable manufacturing business has and will continue to supply the Noma wire and cable assembly business with wire used as a raw material. These sales are expected to continue through 2007, after which
time any future sales will be subject to open market bidding. The principal factors used to conclude that the expected continuing cash flows are not direct cash flows were the length of time the transactions are expected to continue and the
magnitude of the expected transactions versus the expected amount of revenue for the Noma wire and cable assembly business. Based on these and other factors, the expected continuing cash flows have not been and are not expected to be significant.
Revenues between the wire and cable manufacturing business and the Noma wire and cable assembly business that were previously eliminated in consolidation were $0 and $10,326 for the three months ended September 30, 2007 and 2006,
respectively, and $3,007 and $29,170 for the nine months ended September 30, 2007 and 2006, respectively.

Because the net proceeds of the Noma wire and cable assembly business sale were required to be used to repay certain outstanding indebtedness, interest expense of $0 and $1,395 for the
three months ending September 30, 2007 and 2006, respectively, and $677 and $4,025 for the nine months ended September 30, 2007 and 2006, respectively, has been allocated to discontinued operations. This allocation was performed using the
estimated net proceeds of the sale and the interest costs incurred in the periods on the debt that requires the repayment.

-12-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

On April 27, 2007, the Company signed an agreement to sell its wholly owned subsidiary Defiance Testing and Engineering Services, Inc. to Ashok Leyland of Chennai, India for $17,000 in
cash, minus a working capital adjustment of $300. During the first quarter of 2007, the Company recorded an impairment charge of $6,150 to reflect the revised estimated fair value of goodwill of the business based upon the purchase offers
which has been included in income (loss) from discontinued operations. The transaction was completed on July 17, 2007. The business was formerly reported as part of the manufacturing segment.

|The components of assets
        held for sale were as follows:                    |  |                         |       |                        |   |        
|---------------------------------------------------------------------------------- |  | ----------------------- | ----- | ---------------------- | - | -------
|                                                                                  
|                                                                                   |  | September
          30, |       | December
          31,
|                                                                                   |  | 2007                    |       | 2006                  
|Accounts
        receivable                                                        |  | $                       | --    |                        | $ | 41,073 
|Inventories                                                                        |  |                         | --    |                        |   | 40,686 
|Other current
        assets                                                       |  |                         | --    |                        |   | 3,166  
|Property,
        plant and equipment                                              |  |                         | 5,602 |                        |   | 31,086 
|Other assets                                                                       |  |                         | --    |                        |   | 20,283 
|                                                                                   |  | $                       | 5,602 |                        | $ | 136,294
|                                                                                   |  |                         |       |                        |   |        
|The components of liabilities
        of businesses held for sale were as follows: |  |                         |       |                        |   |        
|                                                                                   |  | September
          30, |       | December
          31,
|                                                                                   |  | 2007                    |       | 2006                  
|Accounts
        payable                                                           |  | $                       | --    |                        | $ | 20,389 
|Accrued
        liabilities                                                        |  |                         | --    |                        |   | 10,307 
|Current
        portion of long-term debt                                          |  |                         | --    |                        |   | 457    
|Long-term
        debt                                                             |  |                         | --    |                        |   | 589    
|Other liabilities                                                                  |  |                         | --    |                        |   | 1,011  
|                                                                                   |  | $                       | --    |                        | $ | 32,753 

At September 30, 2007, amounts remaining in assets held for sale represent land and buildings at idle facilities expected to be sold within the next 12 months.

The businesses included in discontinued operations had revenues of $402 and $76,737 and pretax income (loss) of $1,706 and $(2,655) for the three months ended September 30, 2007
and 2006, respectively, and revenues of $40,014 and $283,065 and a pretax loss of $(6,926) and $(4,521) for the nine months ended September 30, 2007 and 2006, respectively.

Note 12  Acquisitions

On February 6, 2007, the Company acquired the assets of Chalum, Inc. for approximately $3,200. The acquisition included the manufacturing facility in Sacaton, Arizona. Chalum produces
aluminum sulfate for the greater Phoenix, Arizona municipal water treatment market. As a result of the acquisition of Chalum, the Company recognized $2,901 of goodwill, all of which is expected to be deductible for tax purposes. The goodwill is
the result of synergies and cost reductions expected to be realized as the facility is assimilated into the Companys network of water treatment chemical production facilities.

-13-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

On September 21, 2006, the Company acquired the assets of GAC MidAmerica, Inc. The acquisition included manufacturing facilities in Toledo, Ohio, Indianapolis, Indiana, and Saukville,
Wisconsin.  GAC produces aluminum sulfate and bleach, as well as distributing specialty water treatment chemicals, sulfuric acid and caustic soda. The purchase price of the transaction was $8,266.

On July 31, 2006, the Company acquired the assets of Precision Engine Products Corp., a wholly owned subsidiary of Stanadyne Corporation.  Precision Engine Products is dedicated principally to
the manufacturing of hydraulic lash adjusters and die cast aluminum rocker arm assemblies utilized in valve train systems for both OEM and after market applications to the global automotive and light truck markets. Precision Engine Products has
manufacturing facilities in Tallahassee, Florida and Curitiba, Brazil.  The purchase price of the transaction was $26,262 in cash, plus the potential of an earn out for Stanadyne of $10,000 twelve months later, based on certain performance
metrics being achieved post closing. As part of the initial purchase price allocation, the Company recorded a liability for the excess of the value of assets purchased over the preliminary purchase price due to the potential for an earn-out payment.
During the third quarter of 2007, it was determined that these performance metrics had not been achieved, and that no additional consideration was due. Accordingly, the liability representing the excess of the values assigned to the assets purchased
over the preliminary purchase price was reversed, and the values assigned to property, plant and equipment were adjusted from $15,990 to $11,172 and the values assigned to intangible assets were adjusted from $4,100 to $3,822.

On July 27, 2006, the Company acquired the assets of Repauno Products, LLC. The acquisition included the manufacturing facility in Gibbstown, New Jersey. Repauno Products manufactures sodium
nitrite which is used in a wide range of industries including metal finishing, heat transfer salts, rubber processing, meat curing, odor control and inks and dyes. The purchase price of the transaction was $6,057.

Operating results for the acquired entities have been reflected in the Companys consolidated financial statements from date of acquisition. The following unaudited pro forma consolidated
financial information has been prepared as if the acquisitions had taken place at the beginning of each fiscal year presented. The following unaudited pro forma information is not necessarily indicative of the results of operations in future periods
or results that would have been achieved had the acquisitions taken place at the beginning of the periods presented.

|                      |  | Three Months
          Ended |         | Nine Months
          Ended
|--------------------- |  | ---------------------------- | ------- | ---------------------------
|                      |  | September
          30,      |         | September
          30,    
|                      |  | 2007                         |         |                            
|                     
|Net revenues          |  | $                            | 151,334 |                            
|Net income            |  |                              | 9,183   |                            
|Net income per share: |  |                              |         |                            
|Basic                 |  | $                            | 0.89    |                            
|Diluted               |  |                              | 0.80    |                            
|                     
|                      |  |                              |         |                            

-14-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Dollars in thousands, except per share data)(unaudited)

The transition adjustment classified as the adjustment to initially apply SFAS 158 was incorrectly included as part of comprehensive income in the consolidated statement of changes in equity
for the year ended December 31, 2006 rather than reflected as an adjustment to the ending balance of accumulated other comprehensive income as of December 31, 2006.

The adjustment to initially apply SFAS 158 incorrectly included a portion of the minimum pension liability adjustment, which is recognized as part of comprehensive income. This immaterial error
resulted in an understatement of comprehensive income as the minimum pension liability adjustment was understated by $3,379 and the adjustment to initially apply SFAS 158 was overstated by the same amount in the consolidated statement of changes
in equity for the year ended December 31, 2006.

The Company incorrectly included the portion of the transition adjustment related to previously unrecognized accumulated actuarial gains due to the impact of the federal subsidy provided under
the Medicare Prescription Drug, Improvement and Modernization Act of 2003 in calculating the deferred tax impact of the transition adjustment to the accumulated projected benefit obligation for other postretirement benefits. However, no deferred
taxes should have been recorded related to this portion of the transition adjustment as the federal subsidy is non-taxable. As a result of this immaterial error, the adjustment to initially apply SFAS 158 to accumulated other comprehensive income
was understated by $2,546 and the net deferred tax balance included in other long term liabilities was overstated by the same amount at December 31, 2006. The Company will correct these errors in their next Form 10-K filing.

Management also determined the condensed consolidated statements of cash flows as reported for the nine months ended September 30, 2006, contained a classification error in the treatment of
costs of property, plant and equipment included in accounts payable.  In accordance with SFAS No. 95, Statement of Cash Flows, these costs should have been reported within cash flows from investing activities when paid.  The Company reported capital
expenditures in its condensed consolidated statements of cash flows on an accrual basis rather than on a cash basis, and as a result, reported capital expenditures in the period in which the Company acquired legal title to the related property,
plant and equipment rather than when the Company actually paid for such property, plant and equipment. Further, the unpaid portion of the transaction should have been disclosed as a non-cash investing activity in the supplemental disclosure of cash
flow information. In addition, the condensed consolidated statement of cash flows as reported for the nine months ended September 30, 2006 reported on a net basis issuance of long-term debt, deferred financing costs paid and amounts borrowed on the
Companys revolving credit facility as opposed to being reported separately.

The
segment presentation for the three and nine months ended September 30, 2006 included
in Note 8 has been restated to remove certain operating segments from the manufacturing
segment which are now presented in corporate and other.

None of the aforementioned errors have an impact on the previously reported consolidated statements of operations for the year ended December 31, 2006 or the three and nine months ended
September 30, 2006.

As a result of the items discussed above, the accompanying condensed consolidated balance sheet as of December 31, 2006, the condensed consolidated statement of changes in equity for the year ended December 31, 2006 and
the condensed consolidated statement of cash flows for the nine months ended September 30, 2006 have been restated as follows:

-15-

---



GENTEK INC.NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (concluded)(Dollars in thousands, except per share data)(unaudited)

|                                                       |  |               |         |   |            |   |                         |   |                       | Discontinued |        |   |  |  
|------------------------------------------------------ |  | ------------- | ------- | - | ---------- | - | ----------------------- | - | --------------------- | ------------ | ------ | - |  | -
|                                                       |  |               |         |   |            |   |                         |   |                       | Operations   |        |   |  |  
|                                                       |  | As Previously |         |   |            |   |                         |   | Adjustments           |              |        |   | 
|                                                       |  | Reported      |         |   | Adjustment |   | (See
          Note 11) |   | As
          Restated
|Condensed consolidated balance
        sheet-December  |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|31, 2006:                                              |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Other
        liabilities                              |  | $             | 72,910  |   |            | $ | (2,546                  | ) |                       | $            | (1,010 | ) |  | $
|Total
        liabilities                              |  |               | 634,273 |   |            |   | (2,546                  | ) |                       |              | --     |   |  |  
|Accumulated
        other comprehensive income         |  |               | 6,004   |   |            |   | 2,546                   |   |                       |              | --     |   |  |  
|Total
        equity                                   |  |               | 95,933  |   |            |   | 2,546                   |   |                       |              | --     |   |  |  
|                                                      
|Condensed consolidated statement
        of changes    |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|in equity-year ended December
        31, 2006:        |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Minimum
        pension liability adjustment           |  |               | 432     |   |            |   | 3,379                   |   |                       |              | --     |   |  |  
|Comprehensive
        income                           |  |               | 7,762   |   |            |   | (5,723                  | ) |                       |              | --     |   |  |  
|Adjustment
        to initially apply FASB             |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Statement
        No.158                               |  |               | 9,102   |   |            |   | (833                    | ) |                       |              | --     |   |  |  
|Accumulated
        other comprehensive income         |  |               | 6,004   |   |            |   | 2,546                   |   |                       |              | --     |   |  |  
|                                                      
|Condensed consolidated statement
        of cash       |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|flows -nine months
        ended September 30, 2006:   |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Cash flows from operating
        activities:          |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Increase
        in accounts payable                   |  |               | 13,446  |   |            |   | (230                    | ) |                       |              | 1,000  |   |  |  
|Net
        cash provided by continuing operations     |  |               | 17,215  |   |            |   | (230                    | ) |                       |              | 17,570 |   |  |  
|Net
        cash provided by operating activities      |  |               | 25,828  |   |            |   | (230                    | ) |                       |              | (1,974 | ) |  |  
|Cash flows from investing
        activities:          |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Capital
        expenditures                           |  |               | (14,664 | ) |            |   | 230                     |   |                       |              | 1,772  |   |  |  
|Net
        cash used for continuing operations        |  |               | (49,775 | ) |            |   | 230                     |   |                       |              | 1,772  |   |  |  
|Net
        cash provided by investing activities      |  |               | (21,007 | ) |            |   | 230                     |   |                       |              | 1,924  |   |  |  
|Cash flows from financing
        activities:          |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Proceeds
        from revolving credit facility        |  |               | --      |   |            |   | 15,000                  |   |                       |              | --     |   |  |  
|Issuance
        of long-term debt                     |  |               | 15,325  |   |            |   | (14,604                 | ) |                       |              | --     |   |  |  
|Repayment
        of long-term debt                    |  |               | (25,370 | ) |            |   | --                      |   |                       |              | 1,630  |   |  |  
|Deferred
        financing costs                       |  |               | --      |   |            |   | (396                    | ) |                       |              | --     |   |  |  
|Supplemental information                               |  |               |         |   |            |   |                         |   |                       |              |        |   |  |  
|Capital
        expenditures incurred but not yet paid |  |               | --      |   |            |   | 2,907                   |   |                       |              | --     |   |  |  

-16-

---



Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.

This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Companys
actual results could differ materially from those set forth in the forward-looking statements. Certain factors that might cause such a difference include those discussed in the section entitled, Managements Discussion and Analysis of
Financial Condition and Results of Operations  Forward-Looking Statements contained in the Companys Annual Report on Form 10-K for the year ended December 31, 2006.

Overview

On July 17, 2007, the Company completed the sale of its wholly owned subsidiary Defiance Testing and Engineering Services, Inc. On February 16, 2007, the Company completed the sale of its Noma
wire and cable harness assembly business. During April 2006, the Company completed the sale of its cable and wire manufacturing business in Stouffville, Canada.  Accordingly, these businesses have been classified as discontinued operations. The net
proceeds from these transactions were used to repay outstanding debt.

On February 6, 2007, the Company acquired the assets of Chalum, Inc. The acquisition included the manufacturing facility in Sacaton, Arizona. Chalum produces aluminum sulfate for the greater
Phoenix, Arizona municipal water treatment market. The purchase price was $3 million.

Results of Operations

The following table sets forth certain line items from our condensed consolidated statements of operations for the three and nine months ended September 30, 2007 and 2006 and the corresponding
percentage of net revenues for the relevant periods presented as a percentage of revenue for the periods indicated.

|                                      |  | Three Months
          Ended    |       | Nine Months
          Ended    
|------------------------------------- |  | ------------------------------- | ----- | -------------------------------
|                                      |  | September
          30,         |       | September
          30,        
|                                      |  | 2007                            |       | 2006                           
|                                      |  | (Dollars
          in millions) |       | (Dollars
          in millions)
|Net revenues                          |  | $                               | 151.3 |                                
|Cost of sales                         |  |                                 | 128.8 |                                
|Selling, general and                  |  |                                 |       |                                
|administrative
        expense        |  |                                 | 13.2  |                                
|Net (gain) on disposition
        of  |  |                                 |       |                                
|long-term
        assets              |  |                                 | (10.1 | )                              
|Restructuring and impairment          |  |                                 |       |                                
|charges                               |  |                                 | 1.7   |                                
|Pension and postretirement            |  |                                 |       |                                
|liability
        curtailment (gains) |  |                                 | (2.6  | )                              
|Operating
        profit              |  |                                 | 20.4  |                                
|Interest expense                      |  |                                 | 5.4   |                                
|Interest income                       |  |                                 | --    |                                
|Other (income) expense, net           |  |                                 | --    |                                
|Income tax provision                  |  |                                 | 6.4   |                                
|Income
        from continuing        |  |                                 |       |                                
|operations                            |  |                                 | 8.6   |                                
|Income
        (loss) from            |  |                                 |       |                                
|discontinued
        operations       |  |                                 | 0.6   |                                
|Net income                            |  | $                               | 9.2   |                                

-17-

---



Three Months Ended September 30, 2007 Compared with Three Months Ended September 30, 2006

Net
revenues were $151 million for the three month period ended September 30,
2007 compared with $159 million for the comparable prior year period. The
shortfall in revenue was  primarily due to lower sales of $7 million in corporate
and other and $6 million in the manufacturing segment partly offset by increased
sales of $6
million in the performance chemicals segment. The shortfall in corporate
and other is the result of lower sales into the industrial wire market. The shortfall
in the manufacturing segment is due to lower sales into the automotive market.
The increase in the performance chemicals segment is due primarily to increased
sales into the water treatment market.

Gross profit was $23 million for the three month period ended September 30, 2007 as compared with $27 million for the comparable prior year period.  This reflects higher gross profit in
the performance chemicals segment of $1 million, offset by a decrease in the manufacturing segment of $5 million.  The increase in the performance chemicals segment gross profit was driven by continued strong performance in the water
treatment market. The shortfall in the manufacturing segment was due primarily to reduced sales of higher margin products in the automotive market base business.

Gains on disposition of long term assets of $10 million were the result of the sale of surplus real estate in Denver, CO, El Segundo, CA, and Atlanta, GA.

Selling, general and administrative expense was $13 million for the three month period ended September 30, 2007 which was flat to the comparable prior year period.

Restructuring and impairment charges were $2 million for the three month period ended September 30, 2007. There were no material charges for the comparable period in the prior year. The
charges recorded in 2007 are primarily associated with the actions to exit from the Perrysburg, OH facility which is included in the manufacturing segment.

Postretirement liability curtailment gains were $3 million for the three month period ended September 30, 2007. There were no gains recorded in the comparable period in the prior year. The
gains recognized in 2007 are primarily associated with the closure of the Perrysburg, OH facility.

Operating profit was $20 million for the three month period ended September 30, 2007 as compared with $14 million for the comparable prior year period. The increased operating profit in
2007 was primarily the result of gains on disposition of long-term assets and favorable postretirement liability curtailment gains in the third quarter of 2007 partly offset by lower gross profit.

Interest expense was $5 million for the three month period ended September 30, 2007 as compared to $6 million in the comparable prior year period due to reduced principal balances and
lower average interest rates.

The effective income tax rate for the three month period ended September 30, 2007 was approximately 43 percent, which is representative of the rate expected to be incurred for the remainder of
the year.

Income from discontinued operations was $1 million for the three month period ended September 30, 2007, reflecting gains on the sale of the Defiance Testing and Engineering Services business.
Loss from discontinued operations in the comparable prior year period reflects the Noma wire and cable assembly business as well as the Defiance Testing and Engineering Services business.

-18-

---



Nine Months Ended September 30, 2007 Compared with Nine Months Ended September 30, 2006

Net
revenues were $466 million for the nine month period ended September 30,
2007 compared with $446 million for the comparable prior year period.  The
increase was primarily due to  higher sales of $22 million in the performance
chemicals segment and higher sales of $8
million in the manufacturing segment partially offset by lower sales of $10 million
in corporate and other. The increase in the performance chemicals segment is
due primarily to increased sales into the water treatment market driven in part
by the acquisitions made in 2006. The increase in the manufacturing segment is
largely the result of the acquisition of Precision Engine Products in 2006. The
shortfall in corporate and other is the result of lower sales into the industrial
wire market.

Gross profit was $78 million for the nine month period ended September 30, 2007 as compared to $82 million in the comparable prior year period. Higher gross profit in the performance
chemicals segment of $6 million was offset by a reduced gross profit of $9 million in the manufacturing segment. The increase in the performance chemicals segment gross profit was primarily driven by strong revenue performance in the water
treatment market. The reduced performance in the manufacturing division was due to reduced sales of higher margin products in the automotive market base business.

Gains on disposition of long term assets of $10 million were the result of the sale of surplus real estate in Denver, CO, El Segundo, CA, and Atlanta, GA.

Selling, general and administrative expense was $39 million for the nine month period ended September 30, 2007 as compared to $38 million in the comparable prior year period. The
increase in SG&A expenses were the result of increased long term incentive plan costs of $1 million as well as increased IT costs associated primarily with a new system installed in the performance chemicals segment of $1 million partly
offset by a one-time $1 million insurance settlement realized in the first quarter.

Restructuring and impairment charges were $5 million for the nine month period ended September 30, 2007 compared to $2
million for the comparable period in the prior year. The charges recorded in
2007 are primarily associated with the actions to exit the Perrysburg, OH facility
which is included in the manufacturing segment and the Newark, NJ sulfuric acid
production facility which is included in the performance chemicals segment.

Curtailment gains were $3 million for the nine month period ended September 30, 2007 as compared to $1 million in the comparable period in the prior year. The gains recognized in 2007
are primarily associated with the closure of the Perrysburg, OH facility.

Operating profit was $48 million for the nine month period ended September 30, 2007 as compared with $43 million for the comparable prior year period. The increased operating profit in
2007 was primarily the result of the gains on the disposition of long term assets partly offset by lower gross profit.

Interest expense was $18 million for the nine month period ended September 30, 2007 as compared to $23 million in the comparable prior year period. Interest expense in the prior year
period included charges of $4 million for costs related to an amendment of the first and second lien term loan agreements and the write-off of certain deferred financing costs versus $1 million of charges in the current year period. Interest
expense in the current period benefited from reduced principal and lower average interest rates resulting in savings of $2 million vs. prior year.

The effective income tax rate for the nine month period ended September 30, 2007 was approximately 42 percent, which is comparable to the 43 percent in the prior year period.

-19-

---



The loss from discontinued operations for the nine month period ended September 30, 2007 was $7 million, which includes an impairment charge of $6 million related to goodwill of the
Defiance Testing and Engineering Services business as compared to $1 million in the prior year period.

|Results of Operations
          by Segment |  |                              |               |                             |  |               |               |          |  |   |       |   |  |   |       |  
|------------------------------------------ |  | ---------------------------- | ------------- | --------------------------- |  | ------------- | ------------- | -------- |  | - | ----- | - |  | - | ----- | -
|                                          
|                                           |  | Three Months
          Ended |               | Nine Months
          Ended
|                                           |  | September
          30,      |               | September
          30,    
|                                           |  | 2007                         |               | 2006                        |  | 2007          |               | 2006    
|Net Revenues                               |  |                              | (In millions) |                             |  | (In millions)
|Manufacturing                              |  | $                            | 32.4          |                             |  | $             | 38.6          |          |  | $ | 119.4 |   |  | $ | 110.9 |  
|Performance chemicals                      |  |                              | 106.4         |                             |  |               | 100.0         |          |  |   | 298.5 |   |  |   | 276.9 |  
|Corporate and other                        |  |                              | 12.6          |                             |  |               | 20.0          |          |  |   | 47.9  |   |  |   | 57.7  |  
|Total                                      |  | $                            | 151.3         |                             |  | $             | 158.5         |          |  | $ | 465.7 |   |  | $ | 445.5 |  
|                                          
|                                           |  | Three Months
          Ended |               | Nine Months
          Ended
|                                           |  | September
          30,      |               | September
          30,    
|                                           |  | 2007 (1)                     |               | 2006 (2)                    |  | 2007 (3)      |               | 2006 (4)
|Operating Profit                           |  |                              | (In millions) |                             |  |               | (In millions) |         
|Manufacturing                              |  | $                            | (0.8          | )                           |  | $             | 2.2           |          |  | $ | 3.3   |   |  | $ | 11.2  |  
|Performance chemicals                      |  |                              | 22.2          |                             |  |               | 12.8          |          |  |   | 45.4  |   |  |   | 34.0  |  
|Corporate and other                        |  |                              | (1.0          | )                           |  |               | (1.1          | )        |  |   | (1.1  | ) |  |   | (2.2  | )
|Total                                      |  | $                            | 20.4          |                             |  | $             | 13.8          |          |  | $ | 47.6  |   |  | $ | 42.9  |  

|(1) | Includes restructuring and impairment charges of $1.6 million in the manufacturing segment and $0.1 million in the performance chemicals segment.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------
|(2) | Includes restructuring and impairment charges of $0.2 million in the manufacturing segment and $0.1 million in the performance chemicals segment.
|(3) | Includes restructuring and impairment charges of $2.8 million in the manufacturing segment and $1.8 million in the performance chemicals segment.
|(4) | Includes restructuring and impairment charges of $1.3 million in the manufacturing segment and $0.3 million in the performance chemicals segment.

Corporate and other

Included
in corporate and other are the results of the Companys
industrial wire and fluid transport and handling equipment product lines, along
with corporate administrative expenses.

Three Months Ended September 30, 2007 Compared with Three Months Ended September 30, 2006

Manufacturing Segment

Net
revenues for the manufacturing segment were $32 million for the three month
period ended September 30, 2007 as compared to $39 million for the comparable
prior year period. This  reduction was the result of lower sales  in the automotive
market of $7 million.  The revenues
into the automotive market reflect  reduced sales volumes sold to historical
OEM automotive and heavy equipment customers. Sales into the heavy equipment
and diesel engine markets were down versus prior year primarily due to a new
engine emission regulation implemented in early  2007, which resulted in strong
prior year sales and a resulting reduction in current year demand. Gross profit
was $1 million for the three month period ended September 30, 2007 as compared
to $6 million for the comparable prior year period.
The decrease in gross profit was primarily due to reduced sales of higher margin
products sold to automotive market base OEM and heavy equipment customers. In
addition, the automotive market business was adversely impacted by a combined $1
 million in manufacturing costs resulting from inefficiencies incurred with the
transition of operations from the Perrysburg, OH facility into the lower cost
Tallahassee, FL location, as well as higher costs to support a new product launch
in the  Toledo, OH facility. Selling, general and administrative expense was $3
million for the three month period ended September 30, 2007 which was favorable $1
million from the comparable prior year period. Lower selling, general and  administrative
costs were related to a reduction in the short-term incentive plan accrual commensurate
with operating unit performance against

-20-

---



targets as well as lower retiree medical expenses. Restructuring and impairment charges were $2 million for the three month period ended September 30, 2007 resulting from the closure of the Perrysburg, OH facility.
Postretirement liability curtailment gains were $3 million for the three month period ended September 30, 2007 resulting from the closure of the Perrysburg, OH facility which drove the accelerated recognition of unrecognized gains resulting from
amendments to the postretirement medical benefit plans. Operating loss was $1 million for the three month period ended September 30, 2007 compared to an operating profit of $2 million for the comparable prior year period. The operating
results were driven by the reduced gross profit in the automotive market partly offset by the postretirement liability curtailment gains.

Performance Chemicals Segment

Net revenues for the performance chemicals segment were $106 million for the three month period ended September 30, 2007 as compared to $100 million for the comparable prior year
period. This was due to higher sales in the Companys water treatment market and personal care products market of $8 million and $1 million, respectively, partly offset by lower sales in the chemical processing market of $3 million
primarily due to the closure of the Newark sulfuric acid production facility.  The increase in sales was the result of higher average pricing and the impact of the acquisitions made in 2006 and early 2007 which are reflected in the water treatment
market sales. Gross profit was $20 million for the three month period ended September 30, 2007 as compared to $20 million for the comparable prior year period.  The gross profit is driven by continued strong revenue performance primarily in
the water treatment market, substantially offset by higher raw material costs and a $3 million increase to the Environmental Liability based on new information and regulatory requirements. Gains on disposition of long-term assets of $10
million were the result of the sale of surplus real estate in Denver, CO, El Segundo, CA, and Atlanta, GA.  Selling, general and administrative expense was $8 million for the three month period ended September 30, 2007 compared with $7
million for the comparable prior year period. The increase in selling, general and administrative expenses was driven by increased costs associated with newly implemented IT systems and increased incentive compensation accruals. Operating profit was
$22 million for the three month period ended September 30, 2007 which increased $9 million from the comparable prior period.  The increase in operating profit was due to the gross margin performance and the gains on disposition of long-term
assets, partially offset by the higher selling, general and administrative expense.

Corporate and Other

The reduction in revenues of $7 million from the prior
year is the result of reduced revenues in the industrial wire market, primarily
driven by the elimination of low margin, commodity wire sales to the recently
sold Norma Wire and Cable Harness Assembly business. These reduced sales were
partly offset by increased sales of higher margin specialty wire products.

Nine Months Ended September 30, 2007 Compared with Nine Months Ended September 30, 2006

Net
revenues for the manufacturing segment were $119
million for the nine month period ended September 30, 2007 as compared to $111
million for the comparable prior year period. This  increase was driven by higher
sales in the automotive market. The revenues into the automotive  market reflect
reduced sales volumes sold to base OEM automotive and heavy equipment customers
which were more than offset by the acquisition of Precision Engine Products in
the third quarter of 2006. Gross profit was $15 million for the nine
month period ended September 30, 2007 as compared to $24 million for the
comparable prior year period. The decrease in gross profit was primarily due
to a mix shift as reduced sales of higher margin products in the automotive market
base  business were offset by lower margin sales associated with the Precision
Engine Products business. The automotive market business was adversely impacted
by a combined $2 million in manufacturing costs related to inefficiencies
incurred with the  transition of operations from the Perrysburg, OH facility
into the lower cost Tallahassee, FL location, as well as higher costs to support
a new product launch in the Toledo, OH facility. In addition, the automotive
market business was adversely  impacted by $1 million in expenses relating
to warranty claim expenses from a customer. Selling, general and administrative
expense was $11 million for the

-21-

---



nine month period ended September 30, 2007 which was flat to the comparable prior year period despite the addition of nearly $1 million in added technical resources required to support new business awards. Restructuring
and impairment charges were $3 million for the nine month period ended September 30, 2007 as compared to $1 million in the comparable prior year period. Postretirement liability curtailment gains were $2 million for the nine month period
ended September 30, 2007 resulting from the closure of the Perrysburg, OH facility which drove the accelerated recognition of unrecognized gains resulting from amendments to the postretirement medical benefit plans. Operating profit of $3
million for the nine month period ended September 30, 2007 compared to an operating profit of $11
million for the comparable prior year period. The operating results were driven
by the reduced gross profit in the automotive market combined with the increased
restructuring and impairment charges partly offset by the postretirement liability
curtailment gains.

Performance Chemicals Segment

Net revenues for the performance chemicals segment were $298 million for the nine month period ended September 30, 2007 as compared to $277 million for the comparable prior year period.
This was due to higher sales in the Companys water treatment market and personal care products market of $26 million and $4 million, respectively, partly offset by lower sales in the chemical processing market of $10 million
primarily due to the closure of the Newark facility. The increase in sales was primarily the result of the higher average pricing and the impact of the acquisitions made in 2006 and early 2007 which are reflected in the water treatment market sales.
Gross profit was $59 million for the nine month period ended September 30, 2007 as compared to $53 million for the comparable prior year period.  The increase in gross profit is primarily attributable to strong revenue performance
particularly in the water treatment market, partially offset by higher raw material costs and a $3 million increase to the environmental liability based on new information and regulatory requirements.  Gains on disposition of long term assets of
$10 million is driven by the sale of surplus real estate. Selling, general and administrative expense was $22 million for the nine month period ended September 30, 2007 compared with $19 million for the comparable prior year period. The
increase in selling, general and administrative expenses was the result of increased allocations of corporate overhead costs as well as increased spending on IT systems and higher accrued incentive compensation costs. Restructuring and impairment
charges were $2 million for the nine month period ended September 30, 2007. These charges relate to the actions to exit the Newark, NJ sulfuric acid production facility. There were no material restructuring and impairment charges in the
comparable prior year period. Pension liability curtailment gains were $1 million for the nine month period ended September 30, 2007 which were flat with the comparable prior period. Operating profit was $45 million for the nine month period
ended September 30, 2007 which was favorable $11 million from the comparable prior period. The increase in operating profit was due to the strong gross margin performance plus the gains on disposition of long-term assets, partially offset by the
higher selling, general and administrative expense and restructuring charges in the current period.

Corporate and Other

Net revenues in corporate and other were $48 million
for the nine month period ended September 30, 2007 as compared to $58 million
for the comparable prior year period. This reduction was the result of lower
sales in the industrial wire market, primarily driven by elimination of low margin,
commodity wire sales to the recently sold Norma Wire and Cable Harness Assembly
business. These reduced sales were partly offset by increased sales of higher
margin specialty wire products. The decrease in operating loss is primarily
the result of a one-time $1 million insurance settlement realized in the first
quarter.

Financial Condition, Liquidity and Capital Resources

Cash and cash equivalents were $13 million at September 30, 2007, compared to $5 million at December 31, 2006.  Significant cash flows during the 2007 period included capital
expenditures of $21 million, net revolver payments of $10 million, debt payments of $135 million, and acquisitions of $3 million, offset by proceeds from sales of assets of $112 million and borrowings of $50 million.

The Company had working capital of $97 million at September 30, 2007 as compared to working capital of $168 million at December 31, 2006. This decrease in working capital principally
reflects a decrease in assets held for sale due to the sale of the Noma wire and cable harness assembly business and the Defiance Testing and Engineering Services, Inc. subsidiary, partially offset by increases in accounts receivable and inventory,
and a decrease in accounts payable.

On March 19, 2007, the Company completed an amendment to its credit facilities which enabled it to increase borrowings under the first lien term loan by $50 million and to use these
borrowings and the net

-22-

---



proceeds from the Noma wire and cable harness assembly business sale to redeem the entire second lien term loan.

Cash payments for employee termination costs and facility exit costs totaled $4 million in the nine months ended September 30, 2007.

The Company expects to make approximately $30-35 million of capital expenditures during 2007.

On August 7, 2007, the Companys board of directors authorized a stock repurchase program pursuant to which the Company will purchase in the aggregate up to $30 million of its common
stock in open market and negotiated purchases over a period of three years, dependent upon market conditions. This program does not obligate the Company to acquire any particular amount of common stock and the program may be suspended at any time at
the Companys discretion.  During the third quarter of 2007, the Company repurchased 75,593 shares for a total of $2 million in accordance with the terms of a Rule 10b5-1 trading program which the Company entered into to effectuate the
stock repurchase program.

Management believes that the Companys cash flow from operations and availability under its revolving credit facility will be sufficient to cover future debt service requirements, capital
expenditures, stock repurchases, and working capital requirements during the remainder of 2007.

Off Balance Sheet Arrangements

The Company has approximately $8 million of standby letters of credit outstanding as of September 30, 2007.

Contractual Obligations

On March 19, 2007, the Company repaid the entire second lien term loan balance of $113 million, which was included in the contractual obligations table in the Companys Annual Report
on Form 10-K for the fiscal year ended December 31, 2006 under long-term debt, with payments due after five years, and borrowed $50 million of additional first lien term loan debt, with payments due of $0.4 million in less than one year,
$1 million in one to three years, and $48.6 million in four to five years.

As a result of the implementation of FIN 48 in the first quarter of 2007, the Company recognized a $2.8 million decrease in the liability for unrecognized tax benefits.  The total amount of
unrecognized tax benefits as of September 30, 2007 was $14.2 million and has been classified as non-current income tax liabilities in the consolidated balance sheet. During the next twelve months, it is reasonably possible that the total amount
of unrecognized tax benefits will significantly change by up to approximately $8 million due to the expiration of statute of limitations or the settlement of examinations. The Company is currently unable to reasonably determine when the
remaining amounts will be resolved.

Recent Accounting Pronouncements

In June 2006, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 48,Accounting for Uncertainty in Income Taxes, an
Interpretation of FASB Statement No. 109(FIN 48). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in a companys financial statements and prescribes a recognition
threshold and measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. The interpretation also provides guidance on derecognition, classification, interest and
penalties, accounting in interim periods, disclosure and transition. The Company adopted FIN 48 on January 1, 2007. The adoption, which was accounted for as a cumulative effect adjustment, resulted in an increase to the January 1, 2007 balance of
retained earnings

-23-

---



(deficit) of $2.8 million. The total amount of unrecognized tax benefits as of January 1, 2007 was $13.5 million, of which $11.5 million would, if recognized, affect the effective tax rate.

In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements, (SFAS 157), to define fair value, establish a framework for measuring fair value in accordance with
generally accepted accounting principles and expand disclosures about fair value measurements. SFAS 157 requires quantitative disclosures using a tabular format in all periods (interim and annual) and qualitative disclosures about the valuation
techniques used to measure fair value in all annual periods. The provisions of this Statement shall be effective for financial statements issued for fiscal years beginning after November 15, 2007 and interim periods within those fiscal years. The
Company will be required to adopt the provisions of this statement as of January 1, 2008. The Company is currently evaluating the impact of adopting SFAS 157.

In February 2007, the FASB issued SFAS No. 159 The Fair Value Option for Financial Assets and Financial Liabilities  including an Amendment of SFAS No. 115, (SFAS No. 159),
which permits an entity to measure many financial assets and financial liabilities at fair value that are not currently required to be measured at fair value. Entities that elect the fair value option will report unrealized gains and losses in
earnings at each subsequent reporting date. The fair value option may be elected on an instrument-by instrument basis, with few exceptions. SFAS No. 159 amends previous guidance to extend the use of the fair value option to available-for-sale and
held-to-maturity securities. The Statement also establishes presentation and disclosure requirements to help financial statement users understand the effect of the election. SFAS No. 159 is effective as of the beginning of the first fiscal year
beginning after November 15, 2007. The Company is currently evaluating the impact of adopting SFAS No. 159.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

The Companys cash flows and earnings are subject to fluctuations resulting from changes in interest rates, foreign currency exchange rates and commodity prices and the Company selectively
uses financial instruments to manage these risks. The Companys objective in managing its exposure to changes in interest rates, foreign currency exchange rates and commodity prices is to reduce volatility on earnings and cash flow associated
with such changes.  The Company has not entered, and does not intend to enter, into financial instruments for speculation or trading purposes.

Interest rate risk

At September 30, 2007, the Companys debt financing consisted primarily of amounts outstanding under the Companys credit facility.  The borrowings outstanding under the
Companys credit facility are collateralized by substantially all of the personal property and certain real property of the Company and its domestic subsidiaries.  Borrowings under the Companys credit facility are sensitive to changes in
interest rates. Given the existing level of borrowings under the credit facility of $247 million as of September 30, 2007, a one percent change in the weighted-average interest rate would have an interest impact of approximately $0.1 million
each month.

|                          |  |                    |  | Weighted-Average
        Interest Rate at |  |                          
|------------------------- |  | ------------------ |  | ----------------------------------------- |  | -------------------------
|Principal
        Balance |  | Fair
        Value |  | September
        30, 2007                |  | Scheduled Maturity       
|$247 million              |  | $240 million       |  | 7.53%                                     |  | February 28,
        2011

In April 2005, the Company entered into two five year interest rate collar agreements in the aggregate notional amount of $185 million, in order to hedge against the effect that interest
rate fluctuations may have on the Companys floating rate debt.  The interest rate to be paid will be based on a minimum three-month LIBOR of 4.05 percent on average and a maximum three-month LIBOR of 5.00 percent. These interest rate collar
agreements are scheduled to mature in 2010.  The fair value of the agreements was $0.1 million at September 30, 2007.

-24-

---



Foreign currency exchange rate and commodity price risks

The Company measures the market risk related to its holding of financial instruments based on changes in foreign currency rates and commodity prices using a sensitivity analysis. The
sensitivity analysis measures the potential loss in fair values, cash flows and earnings based on a hypothetical 10 percent change in foreign currency exchange rates and commodity prices. Such analysis indicates that a hypothetical 10 percent change
in foreign currency exchange rates or commodity prices would not have a material impact on the fair values, cash flows or earnings of the Company.

Item 4.  Controls and Procedures.

(a) Disclosure Controls and Procedures.

The Companys management, with the participation of the Companys Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Companys disclosure
controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of September 30, 2007. Based on such evaluation, the Companys Chief
Executive Officer and Chief Financial Officer have concluded that, as of as of September 30, 2007, the Companys disclosure controls and procedures are effective at the reasonable assurance level.

(b) Changes in Internal Control Over Financial Reporting.

There
have not been any changes in the Companys internal control over financial
reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act) during the  fiscal quarter to which this report relates that have
materially affected, or are reasonably likely to materially affect, the Companys
internal control over financial reporting.

-25-

---



PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

In May, 2007, the Company was notified by the Northwest Clean Air Agency in Mount Vernon, WA (the Agency), that the Agency had imposed penalties totaling $224,000 in connection
with alleged violations of the Companys Title V Facility Air Operating Permit at its Anacortes, WA facility. The Company and the Agency entered into a settlement whereby the Company agreed to pay $82,500 in exchange for a release of all
claims relating to the alleged violations.

Item 1A. Risk Factors

There have been no material changes from risk factors as previously disclosed by the Company in its Annual Report on Form 10-K for the fiscal year ended December 31, 2006.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities

|                     |  |           |  |                          |       |           | (c) Total              |                        | (d)         
|-------------------- |  | --------- |  | ------------------------ | ----- | --------- | ---------------------- | ---------------------- | ------------
|                     |  |           |  |                          |       |           | Number of              |                        | Approximate 
|                     |  |           |  |                          |       |           | Shares                 |                        | Dollar Value
|                     |  |           |  |                          |       |           | Purchased
          as |                        | Of Shares   
|                     |  | (a) Total |  |                          |       | Part of   |                        | That May
          Yet
|                     |  | Number of |  | (b) Average              |       | Publicly  |                        | Be Purchased          
|                     |  | Shares    |  | Price Paid
          per |       | Announced |                        | Under the             
|                     |  | Purchased |  | Share                    |       | Program   |                        | Program               
|                    
|                    
|July 1-31, 2007      |  | --        |  | $                        | --    |           | $                      | --                     |             
|August1-31, 2007     |  | --        |  |                          | --    |           |                        | --                     |             
|September 1-30, 2007 |  | 75,593    |  |                          | 29.73 |           |                        | 2,249,647              |             
|Total                |  | 75,593    |  | $                        | 29.73 |           | $                      | 2,249,647              |             

On August 7, 2007, the Company announced a stock repurchase program pursuant to which the Company may purchase in the aggregate up to $30 million of its common stock.  The program expires
on August 7, 2010.

|Item 3. |  | Defaults Upon Senior Securities.                              
|------- |  | --------------------------------------------------------------
|        |  |                                                               
|        |  | NONE                                                          
|        |  |                                                               
|Item 4. |  | Submission of Matters
          to a Vote of Security Holders.
|        |  |                                                               
|        |  | NONE                                                          
|        |  |                                                               
|Item 5. |  | Other Information.                                            
|        |  |                                                               
|        |  | NONE                                                          

-26-

---



Item 6. Exhibits.

| | Exhibit No. | Description                                                                                                                                                                                                                                                                                                                                                                                                                                              
| | ----------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 2.1         | Joint Plan of Reorganization
          Under Chapter 11, Title 11, United States Code of GenTek Inc., et al.,
          and Noma Company, Debtors, dated August 28, 2003, as filed with the
          United States Bankruptcy Court for the District of Delaware on August
          28, 2003 (incorporated by reference to Exhibit 2.1 of the Registrants
    Form 8-K, filed with the Commission on October 21, 2003).                               
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 2.2         | First Modification
          to Joint Plan of Reorganization Under Chapter 11, Title 11, United
          States Code of GenTek Inc., et al., and Noma Company, Debtors, dated
          October 3, 2003 as filed with the United States Bankruptcy Court for
          the District of Delaware on October 3, 2003 (incorporated by reference
          to Exhibit 2.2 of the Registrants Form 8-K, filed with the Commission
    on October 21, 2003).
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 2.3         | Order confirming
          Joint Plan of Reorganization Under Chapter 11, Title 11, United States
          Code of GenTek Inc., et al., and Noma Company, Debtors, as Modified,
          as entered by the United States Bankruptcy Court for the District of
          Delaware on October 7, 2003 (incorporated by reference to Exhibit 2.3
          of the Registrants Form 8-K, filed with the Commission on October
    21, 2003).              
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 3.1         | Third Amended and
          Restated Certificate of Incorporation of GenTek Inc., effective as
          of May 9, 2006 (incorporated by reference to the Registrants
          Form 10-Q, dated June 30, 2006, as filed with the Securities and Exchange
    Commission).                                                                                                                                                                              
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 3.2         | Second Amended and
          Restated By Laws of GenTek Inc., effective as of August 7, 2007 (incorporated
          by reference to the Registrant's Form 8-K, dated August 7, 2007, as
    filed with the Securities and Exchange Commission).                                                                                                                                                                                                         
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 4.1         | GenTek Inc. Tranche
          B Warrant Agreement, dated as of November 10, 2003 (incorporated by
          reference to the Registrant's Form 8-A to amend its Form 10, dated
    November 10, 2003, as filed with the Securities and Exchange Commission).                                                                                                                                                                                             
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 4.2         | GenTek Inc. Tranche
          C Warrant Agreement, dated as of November 10, 2003 (incorporated by
          reference to the Registrant's Form 8-A to amend its Form 10, dated
    November 10, 2003, as filed with the Securities and Exchange Commission).                                                                                                                                                                                             
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 10.1        | Form of Registration
          Rights Agreement by and among the Company and the holders named therein
          dated as of November 10, 2003 (incorporated by reference to the Registrant's
          Form 8-A to amend its Form 10, dated November 10, 2003, as filed with
    the Securities and Exchange Commission).                                                                                                                               
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 10.2        | GenTek Inc. 2003
          Management and Directors Incentive Plan (incorporated by reference
          to the Registrants Form 10-Q dated September 30, 2003, as filed
    with the Securities and Exchange Commission).                                                                                                                                                                                                                               
| |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                          
| | 10.3        | GenTek Key Employee
          Retention Plan (incorporated by reference to Exhibit 10.14 to the Registrants
          Form 10-K/A dated April 30, 2003, as filed with the Securities and
    Exchange Commission).                                                                                                                                                                                                                                      

-27-

---



| | 10.4  | Form of Indemnification
          Agreement (incorporated by reference to the Registrant's Form 10-K
          dated December 31, 2003, as filed with the Securities and Exchange
    Commission).                                                                                                                                                                                                                                                                                                                                                                                                                                 
| | ----- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.5  | GenTek Performance
          Plan (incorporated by reference to the Exhibit 10.3 to the Registrants
          Amendment No. 2 to Form 10, dated April 8, 1999, as filed with the
    Securities and Exchange Commission).                                                                                                                                                                                                                                                                                                                                                                                                         
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.6  | Tax Sharing Agreement
          between GenTek Inc. and the General Chemical Group Inc. (incorporated
          by reference to the Exhibit 10.6 to the Registrants Amendment
          No. 2 to Form 10, dated April 8, 1999, as filed with the Securities
    and Exchange Commission).                                                                                                                                                                                                                                                                                                                                         
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.7  | Share Purchase Agreement
          by and among ADC Telecommunications Inc., Krone International Holding
          Inc., Krone Digital Communications Inc., GenTek Holding Corporation,
          and GenTek Inc., dated March 25, 2004 (incorporated by reference to
          Exhibit 10.14 of the Registrants Form 10-Q for the period ended
    June 30, 2004, as filed with the Securities and Exchange Commission).                                                                                                                                                                                                         
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.8  | Form of Director
          Restricted Stock Agreement (incorporated by reference to the Registrants
          Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange
    Commission).                                                                                                                                                                                                                                                                                                                                                                                                                           
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.9  | Form of Performance
          Contingent Restricted Stock Agreement (incorporated by reference to
          the Registrants Form 10-Q dated June 30, 2007, as filed with
    the Securities and Exchange Commission).                                                                                                                                                                                                                                                                                                                                                                                                             
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.10 | Form of Restricted
          Stock Agreement (incorporated by reference to the Registrants
          Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange
    Commission).                                                                                                                                                                                                                                                                                                                                                                                                                                    
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.11 | Form of Stock Option
          Agreement (incorporated by reference to the Registrants Form
          10- Q dated June 30, 2004, as filed with the Securities and Exchange
    Commission).                                                                                                                                                                                                                                                                                                                                                                                                                                       
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.12 | Form of Performance
          Cash Award Agreement (incorporated by reference to the Registrants
          Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange
    Commission).                                                                                                                                                                                                                                                                                                                                                                                                                              
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.13 | Master Settlement
          Agreement, dated April 30, 2004, among GenTek Holding Corporation,
          General Chemical LLC, and Honeywell International Inc. (incorporated
          by reference to the Registrants Form 10-Q dated September 30,
    2004, as filed with the Securities and Exchange Commission).                                                                                                                                                                                                                                                                                                            
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.14 | First Lien Credit
          and Guaranty Agreement among GenTek, Inc., GenTek Holding LLC, as borrower,
          the other guarantors party thereto, the lenders party thereto from
          time to time, Goldman Sachs Credit Partners L.P., as joint lead arranger,
          General Electric Capital Corporation, as co-administrative agent, and
          Bank of America, N.A., as co-administrative agent and collateral agent,
          dated February 28, 2005 (incorporated by reference to the Registrants
          Form 10-K dated December 31, 2004, as filed with the Securities and
    Exchange Commission).
| |       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
| | 10.15 | Second Lien Credit
          and Guaranty Agreement among GenTek, Inc., GenTek Holding LLC, as borrower,
          the other guarantors party thereto, the lenders party thereto from
          time to time, Goldman Sachs Credit Partners L.P., as joint lead arranger,
          sole bookrunner, syndication agent, administrative agent and as collateral
    agent, Bank of America                                                                                                                                                                                                                                          

-28-

---



| |       | Securities LLC,
          as joint lead arranger and Bank of America, N.A., as documentation
          agent, dated February 28, 2005 (incorporated by reference to the Registrants
          Form 10-K dated December 31, 2004, as filed with the Securities and
    Exchange Commission).                   
| | ----- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.16 | Employment Agreement
          with William E. Redmond, Jr., dated May 23, 2005 (incorporated by reference
          to the Registrants Form 10-Q dated September 30, 2005, as filed
    with the Securities and Exchange Commission).                                                                        
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.17 | Employment agreement
          with Andrew Hines, dated September 21, 2005 (incorporated by reference
          to the Registrants Form 10-Q dated September 30, 2005, as filed
    with the Securities and Exchange Commission).                                                                             
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.18 | Employment agreement
          with Maximo Vargas, dated September 22, 2005 (incorporated by reference
          to the Registrants Form 10-Q dated September 30, 2005, as filed
    with the Securities and Exchange Commission).                                                                            
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.19 | Asset Purchase Agreement
          dated April 3, 2006 between Noma Company and Southwire Canada Company
          (incorporated by reference to the Registrants Form 8-K dated
    April 3, 2006, as filed with the Securities and Exchange Commission).                                                     
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.20 | First Amendment
          to First Lien Credit and Guaranty Agreement and Pledge and Security
          Agreement dated April 26, 2006 (incorporated by reference to the Registrants
          Form 8-K dated April 26, 2006, as filed with the Securities and Exchange
    Commission).                      
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.21 | First Amendment
          to Second Lien Credit and Guaranty Agreement dated April 26, 2006 (incorporated
          by reference to the Registrants Form 8-K dated April 26, 2006,
    as filed with the Securities and Exchange Commission).                                                                 
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.22 | Asset Purchase Agreement
          dated June 30, 2006 between Defiance, Inc., Precision Engine Products
          Corp. and Stanadyne Corporation (incorporated by reference to the Registrants
          Form 8-K dated June 30, 2006, as filed with the Securities and Exchange
    Commission).           
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.23 | Second Amendment
          to First Lien Credit and Guaranty Agreement dated July 14, 2006 (incorporated
          by reference to the Registrants Form 10-Q dated June 30, 2006,
    as filed with the Securities and Exchange Commission).                                                                  
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.24 | Second Amendment
          to Second Lien Credit and Guaranty Agreement dated July 14, 2006 (incorporated
          by reference to the Registrants Form 10-Q dated June 30, 2006,
    as filed with the Securities and Exchange Commission).                                                                 
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.25 | Letter Agreement
          with James Imbriaco, dated July 27, 2006 (incorporated by reference
          to the Registrants Form 8-K dated August 4, 2006, as filed with
    the Securities and Exchange Commission).                                                                                         
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.26 | Asset Purchase Agreement
          dated December 22, 2006 between Electrical Components International,
          Inc., Noma Holding Inc. and GenTek Inc. (incorporated by reference
          to the Registrants Form 8-K dated December 22, 2006, as filed
    with the Securities and Exchange Commission).
| |       |                                                                                                                                                                                                                                                                                                                
| | 10.27 | Third Amendment
          to First Lien Credit and Guaranty Agreement and waiver dated March
          19, 2007 (incorporated by reference to the Registrants Form 10-K
          dated December 31, 2006, as filed with the Securities and Exchange
    Commission).                                         
| |       |                                                                                                                                                                                                                                                                                                                

-29-

---



| | 10.28 | GenTek Inc. Directors
          Deferred Compensation Program.                                                                                                                                              
| | ----- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |       |                                                                                                                                                                                                             
| | 31.1  | Certification of
          Chief Executive Officer pursuant to Rule 13a 14(a)/15d-14(a) as adopted
          pursuant to Section 302 of the Sarbanes-Oxley Actof
          2002.                            
| |       |                                                                                                                                                                                                             
| | 31.2  | Certification of
          Chief Financial Officer pursuant to Rule 13a 14(a)/15d-14(a) as adopted
          pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                     
| |       |                                                                                                                                                                                                             
| | 32    | Certification of
          Chief Executive Officer and Chief Financial Officer pursuant to 18
          U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley
          Act of 2002.

-30-

---



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned there unto duly
authorized.

|                                 |  |     | GENTEK
        INC.                                       
|-------------------------------- |  | --- | ----------------------------------------------------------
|                                 |  |     | Registrant                                                
|                                
|                                
|                                
|Date   November
        9, 2007  |  | /s/ | William
        E. Redmond, Jr.                           
|                                 |  |     | William E. Redmond, Jr.                                   
|                                 |  |     | President and Chief Executive
        Officer and Director
|                                 |  |     | (Principal Executive Officer)                             
|                                
|                                
|                                
|Date    November
        9, 2007 |  | /s/ | Thomas
        B. Testa                                   
|                                 |  |     | Thomas B. Testa                                           
|                                 |  |     | Vice President and Chief
        Financial Officer        
|                                 |  |     | (Principal Financial and
        Accounting Officer)      

-31-

---